Thanks to deception like that we see here from Dr. Fiore, there is a perception that the use of smoking cessation drugs is the "standard of care." This is far from the truth. If the public, and tobacco practitioners themselves, understood the depth of the connection between those who crafted the "standard of care" (i.e., the Clinical Practice Guideline recommendations) and the industry that manufactures the drugs that are recommended in the Guideline, it would become apparent that these recommendations are heavily biased, not objective, and inappropriate.

In fact, it appears that many anti-smoking advocates and groups do not actually want smokers to quit using e-cigarettes. They would rather smokers continue to smoke than to use a device which looks like a cigarette but is actually much safer. After all, for most smokers who quit using e-cigarettes, advice telling them not to use the e-cigarette is tantamount to instructing them to return to cigarette smoking. The chances that such smokers will succeed with FDA-approved methods is near nil. In fact, the very reason that most of them have tried e-cigarettes in the first place is because they had tried FDA-approved methods in the past and failed or they had little confidence that such methods would work.

The reason I resigned from the ANR Executive Board was that the organization told me that it placed a higher value on its political objectives than on scientific integrity. This story illustrates that ANR continues to operate on this unethical strategy.

What is most disturbing to me about this story is that there is clearly no room for a difference in opinion in the tobacco control movement about certain dogmatic elements of the field. You can't express disagreement without facing personal attack, no matter how well you support your argument with scientific evidence. Like a religion, you can't challenge the gospel-like nature of movement's mantra without being viewed as a heretic.

"During the Senate committee debate on the bill, Republican members offered for consideration language that would grant the FDA authority to regulate e-cigarettes as tobacco products and restrict the agency from regulating them as medical products. But the sponsors of the bill and the FDA leadership under the new administration wanted the option to use the FDA’s medical product regulatory authority, so they were not open to including “regulate once but not twice” language. The amendment was withdrawn." ...

LAST：NEW DESIGAN!!! 2013 Newest e cigarette EVOD ecig pcc 2013 ecigarette pcc |NEXT：2014 Pen style and portable health electronic cigarette ego w with factory price